Question 1

Does UBS Group own SMMT stock?

Accepted Answer

Yes. As of its Q2 2026 13F, UBS Group holds 5,233,798 shares of SMMT (Summit Therapeutics), worth $76.3M.

Question 2

How many shares of SMMT does UBS Group own?

Accepted Answer

As of its Q2 2026 13F, UBS Group holds 5,233,798 shares of SMMT (Summit Therapeutics).

Question 3

What is UBS Group's SMMT position worth?

Accepted Answer

As of its Q2 2026 13F, UBS Group's SMMT position is worth $76.3M.

Question 4

Is UBS Group buying or selling SMMT?

Accepted Answer

In Q2 2026, UBS Group increased its SMMT position by 1,553,483 shares (+42.2%).

Question 5

When did UBS Group first buy SMMT?

Accepted Answer

UBS Group first reported SMMT in its Q3 2020 13F and has listed it in 24 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	5.2M	+42.2%	$76.3M	0.0%	$14.57	40
2026-Q1	Increased	3.7M	+322.7%	$69.8M	0.0%	$15.11	48
2025-Q4	Decreased	870,719	-31.9%	$15.2M	0.0%	$17.49	0
2025-Q3	Decreased	1.3M	-38.9%	$26.4M	0.0%	$21.16	0
2025-Q2	Increased	2.1M	+65.6%	$44.6M	0.0%	$20.60	43
2025-Q1	Increased	1.3M	+6.6%	$24.4M	0.0%	$20.32	31
2024-Q4	Increased	1.2M	+890.1%	$21.2M	0.0%	$17.89	46
2024-Q3	Decreased	119,819	-28.6%	$2.6M	0.0%	$20.89	0